Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference

Company Overview - Pacira BioSciences, Inc. is a leader in delivering innovative, non-opioid pain therapies aimed at transforming patient lives [2] - The company has three commercial-stage non-opioid treatments: EXPAREL®, ZILRETTA®, and iovera® [2] - EXPAREL® is a long-acting local analgesic approved for various postsurgical pain management techniques [2] - ZILRETTA® is an extended-release injectable for managing osteoarthritis knee pain [2] - iovera® is a handheld device providing immediate, long-acting, drug-free pain control through controlled cold temperature application [2] - Pacira is advancing a pipeline of clinical-stage assets, including PCRX-201, a gene therapy for osteoarthritis of the knee currently in Phase 2 clinical development [2] Upcoming Events - Pacira will participate in an analyst-led fireside chat at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026 [1] - The event will take place at 2:30 PM ET in Miami, with live audio accessible on the company's website [1] - A replay of the webcast will be available for two weeks following the event [1]